| Authors: |
Eckhardt BL; Morgan Welch Inflammatory Breast Cancer Research and Clinic, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. robin.anderson@onjcri.org.au bedrich.eckhardt@onjcri.org.au.; Olivia Newton-John Cancer Research Institute, Heidelberg, Australia., Cao Y; Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria, Australia., Redfern AD; School of Medicine, University of Western Australia, Perth, Australia., Chi LH; Olivia Newton-John Cancer Research Institute, Heidelberg, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia., Burrows AD; Olivia Newton-John Cancer Research Institute, Heidelberg, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia., Roslan S; Olivia Newton-John Cancer Research Institute, Heidelberg, Australia., Sloan EK; Monash Institute of Pharmaceutical Sciences, Drug Discovery Biology Theme, Monash University, Parkville, Victoria, Australia., Parker BS; La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Victoria, Australia., Loi S; Research Division, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Ueno NT; Morgan Welch Inflammatory Breast Cancer Research and Clinic, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lau PKH; Department of Health Western Australia, Perth, Australia.; Cancer Medicine, Peter MacCallum Cancer Centre, Parkville, Australia., Latham B; Department of Anatomical Pathology, Fiona Stanley Hospital, Perth, Australia., Anderson RL; Olivia Newton-John Cancer Research Institute, Heidelberg, Australia. robin.anderson@onjcri.org.au bedrich.eckhardt@onjcri.org.au.; School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia.; Research Division, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia. |
